high dose semaglutide Higher of increases weight loss, metabolic benefits: Newsroom GLP-1 Drugs Lower Risk of

While GLP-1 receptor agonist therapy leads to greater relative fat loss than lean mass loss, preserving muscle tissue requires adequate protein intake and resistance exercise during weight reduction

Insulin and insulin resistance

A., Nothaft, W., Awni, W

Reported side effects included: Nausea (most common, particularly during dose escalation) Vomiting Diarrhea Constipation Decreased appetite (this is also the mechanism, so it is both a side effect and the goal) Discontinuation due to side effects in the Phase 2 trial was around 16% in the highest dose group

PubMed laboratory research record [PMID: 11849462] PubMed record related to this compound for laboratory literature review